11-Oxo-15S-hydroxy-5Z,8Z,13E-prostatrienoic acid
|
http://id.nlm.nih.gov/mesh/2021/C037112 |
|
1-(1-Phenylcyclohexyl)piperidine
|
http://id.nlm.nih.gov/mesh/2021/D010622 |
|
11p partial monosomy syndrome (disorder)
|
http://id.nlm.nih.gov/mesh/2021/D017624 |
|
11p partial monosomy syndrome
|
http://id.nlm.nih.gov/mesh/2021/D017624 |
|
11q Terminal Deletion Disorder
|
http://id.nlm.nih.gov/mesh/2021/D054868 |
|
1-[(1S,2R,5R,11S,14S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-yl]ethan-1-one
|
http://id.nlm.nih.gov/mesh/2021/D011284 |
|
(11S)-6alpha-hydroxy-3-oxoeudesma-1,4-dien-12-oic acid gamma-lactone
|
http://id.nlm.nih.gov/mesh/2021/D012500 |
|
1,1'-Sulfonylbis(4-aminobenzene)
|
http://id.nlm.nih.gov/mesh/2021/D003622 |
|
1,1'-Sulfonylbis[4-aminobenzene]
|
http://id.nlm.nih.gov/mesh/2021/D003622 |
|
1,1'-Sulphonylbisethene
|
http://id.nlm.nih.gov/mesh/2021/C009873 |
|